Sangamo Therapeutics (SGMOQ) FCF Margin Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) FCF Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -63,107.00 |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 4.25 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 12,129.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | 190,033.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -1.35 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 86,497.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | 10,262.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 371.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 6,534.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6,534.00 |
| Sep 30, 2025 | -468,344.00 |
| Jun 30, 2025 | 10,383.00 |
| Mar 31, 2025 | -19,091.00 |
| Dec 31, 2024 | 14,889.00 |
| Sep 30, 2024 | 25,015.00 |
| Jun 30, 2024 | -732,944.00 |
| Mar 31, 2024 | -992,159.00 |
| Dec 31, 2023 | -257,354.00 |
| Sep 30, 2023 | -58,273.00 |
| Jun 30, 2023 | -169,807.00 |
| Mar 31, 2023 | 12,490.00 |
| Sep 30, 2022 | 6,965.00 |
| Jun 30, 2022 | 16,646.00 |
| Mar 31, 2022 | 41,412.00 |
| Dec 31, 2021 | 5,555.00 |
| Sep 30, 2021 | -6,984.00 |
| Jun 30, 2021 | -77,167.00 |
| Mar 31, 2021 | -12,690.00 |
| Dec 31, 2020 | 10,331.00 |